Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 20;11(4):366.
doi: 10.3390/v11040366.

Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases

Affiliations
Review

Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases

Andrei S Bolocan et al. Viruses. .

Abstract

Bacteriophages (phages) or bacterial viruses have been proposed as natural antimicrobial agents to fight against antibiotic-resistant bacteria associated with human infections. Enterococcus faecalis is a gut commensal, which is occasionally found in the mouth and vaginal tract, and does not usually cause clinical problems. However, it can spread to other areas of the body and cause life-threatening infections, such as septicemia, endocarditis, or meningitis, in immunocompromised hosts. Although E. faecalis phage cocktails are not commercially available within the EU or USA, there is an accumulated evidence from in vitro and in vivo studies that have shown phage efficacy, which supports the idea of applying phage therapy to overcome infections associated with E. faecalis. In this review, we discuss the potency of bacteriophages in controlling E. faecalis, in both in vitro and in vivo scenarios. E. faecalis associated bacteriophages were compared at the genome level and an attempt was made to categorize phages with respect to their suitability for therapeutic application, using orthocluster analysis. In addition, E. faecalis phages have been examined for the presence of antibiotic-resistant genes, to ensure their safe use in clinical conditions. Finally, the domain architecture of E. faecalis phage-encoded endolysins are discussed.

Keywords: E. faecalis; OrthoMCL; phage therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Genomic comparison of Enterococcus phages. (A) Neighbor-joining tree based on the percentage of shared orthologous genes (1000 bootstrap replicates); squares indicate the 10 phage putative orthoclusters. (B) Dot plot comparison of amino acids identity among the 10 orthoclusters; genes that share more than 40% homology were considered as being part of the same orthologous group. The vertical axis shows phage clusters and phage IDs.
Figure 2
Figure 2
Maximum likelihood phylogenetic analysis sequence relatedness of the Enterococcus faecalis phage putative metallo-beta-lactamase gene (orthologous group 32); tree node labels represent bootstrap values.
Figure 3
Figure 3
Maximum likelihood phylogenetic analysis sequence relatedness of E. faecalis phage endolysin functional domains; tree node labels represent the bootstrap values; the sequence similarity between functional domains is evidenced by using identical filling patterns; in blue—active domain; in orange—biding in domain; each of the four orthologous group is represented by a different color; Ef62phi could not be associated to any orthologous group.

Similar articles

Cited by

References

    1. Arias C.A., Contreras G.A., Murray B.E. Management of multidrug-resistant enterococcal infections. Clin. Microbiol. Infect. 2010;16:555–562. doi: 10.1111/j.1469-0691.2010.03214.x. - DOI - PMC - PubMed
    1. Sava I.G., Heikens E., Huebner J. Pathogenesis and immunity in enterococcal infections. Clin. Microbiol. Infect. 2010;16:533–540. doi: 10.1111/j.1469-0691.2010.03213.x. - DOI - PubMed
    1. Berg R.D. The indigenous gastrointestinal microflora. Trends Microbiol. 1996;4:430–435. doi: 10.1016/0966-842X(96)10057-3. - DOI - PubMed
    1. Facklam R.R., da Carvalho M.G.S., Teixeira L.M. The Enterococci. American Society of Microbiology; Washington, DC, USA: 2002. History, Taxonomy, Biochemical Characteristics, and Antibiotic Susceptibility Testing of Enterococci; pp. 1–54.
    1. Simonsen G.S., Småbrekke L., Monnet D.L., Sørensen T.L., Møller J.K., Kristinsson K.G., Lagerqvist-Widh A., Torell E., Digranes A., Harthug S., et al. Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J. Antimicrob. Chemother. 2003;51:323–331. doi: 10.1093/jac/dkg052. - DOI - PubMed

Publication types

Substances